ESG

A novel drug candidate from Addex Therapeutics shows robust cough suppression in key preclinical studies, offering hope for a treatment without current side effects.

Backed by diplomacy and sustainability, two Southeast Asian giants are leveraging design innovation to challenge the competitive North American tile industry.

EcoMatcher's new 'Tree Personas' let you chat with your gifted tree via an AI personality, blending digital engagement with real-world conservation.

A new alliance plans to bring ambient AI and robotic assistants to the operating room, promising a revolution in surgical efficiency and patient care.

With record global attendance and a focus on AI, drones, and sustainability, CCE 2026 in Shanghai showcased a cleaning industry in radical transformation.

With a $719M war chest from its blockbuster IPO, Kailera Therapeutics is poised to challenge the dominance of Lilly and Novo in the lucrative obesity market.

Canadian steelworkers raise funds for critical medical supplies in Cuba, responding to a severe humanitarian crisis worsened by blockades and blackouts.

As tough new EPA rules on PFAS create a multi-billion dollar market, a major investment in a novel, plant-based filter aims to dominate U.S. water cleanup.

At Harvard, a Chinese firm's 'Strategic Product' model is gaining acclaim. See how Kmind Consulting's human-centric approach is fueling global hits.

As the EPA sounds new alarms on microplastics, a new wave of smart water purifiers offering subscription-based purity is flowing into American homes.

Ankara champions a global zero-waste agenda for the COP31 climate summit, but its own domestic energy policies and emissions targets face growing scrutiny.

Freshly spun-off from AnaptysBio, First Tracks Biotherapeutics hits the market with a strong cash position and a pipeline aimed at celiac disease and RA.

UAB Kvartalas completes its flagship office project but reports €3.5M in losses, calling a critical meeting as a €40.6M bond payment deadline nears.

As cyber threats loom, Rpharmy's SOC 2 Type II audit signals a deep commitment to protecting sensitive patient data and ensuring system reliability.

As leaders gather for the 70th OSUM conference, 'strong mayor' powers, homelessness, and the upcoming election dominate a high-stakes agenda.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

Atsena Therapeutics gets the green light for the final trial phase of a promising gene therapy, offering the first real hope for patients with X-linked retinoschisis.

The 15-year partnership between Kia and TotalEnergies is renewed, focusing on cutting-edge lubricants and solutions for the growing EV market.

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

As the fiber market booms, one brand's two-decade success reveals a powerful link between regenerative agriculture, consumer trust, and digestive wellness.